BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33719168)

  • 21. Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment.
    Schelb P; Kohl S; Radtke JP; Wiesenfarth M; Kickingereder P; Bickelhaupt S; Kuder TA; Stenzinger A; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
    Radiology; 2019 Dec; 293(3):607-617. PubMed ID: 31592731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge.
    Hosseinzadeh M; Saha A; Brand P; Slootweg I; de Rooij M; Huisman H
    Eur Radiol; 2022 Apr; 32(4):2224-2234. PubMed ID: 34786615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical study of multifactorial diagnosis in prostate biopsy.
    Li J; Wang K; Li S; Wu P; Wang X; He Y; Tang W
    Prostate; 2023 Nov; 83(15):1494-1503. PubMed ID: 37545333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RAPHIA: A deep learning pipeline for the registration of MRI and whole-mount histopathology images of the prostate.
    Shao W; Vesal S; Soerensen SJC; Bhattacharya I; Golestani N; Yamashita R; Kunder CA; Fan RE; Ghanouni P; Brooks JD; Sonn GA; Rusu M
    Comput Biol Med; 2024 May; 173():108318. PubMed ID: 38522253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of ISUP ≥2 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS V.2.1 score (CHANGE study).
    Rouvière O; Souchon R; Lartizien C; Mansuy A; Magaud L; Colom M; Dubreuil-Chambardel M; Debeer S; Jaouen T; Duran A; Rippert P; Riche B; Monini C; Vlaeminck-Guillem V; Haesebaert J; Rabilloud M; Crouzet S
    BMJ Open; 2022 Feb; 12(2):e051274. PubMed ID: 35140147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.
    Bulten W; Pinckaers H; van Boven H; Vink R; de Bel T; van Ginneken B; van der Laak J; Hulsbergen-van de Kaa C; Litjens G
    Lancet Oncol; 2020 Feb; 21(2):233-241. PubMed ID: 31926805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using support vector machine analysis to assess PartinMR: A new prediction model for organ-confined prostate cancer.
    Wang J; Wu CJ; Bao ML; Zhang J; Shi HB; Zhang YD
    J Magn Reson Imaging; 2018 Aug; 48(2):499-506. PubMed ID: 29437268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate.
    Johnson PM; Tong A; Donthireddy A; Melamud K; Petrocelli R; Smereka P; Qian K; Keerthivasan MB; Chandarana H; Knoll F
    J Magn Reson Imaging; 2022 Jul; 56(1):184-195. PubMed ID: 34877735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
    Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
    Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep-Learning Models for Detection and Localization of Visible Clinically Significant Prostate Cancer on Multi-Parametric MRI.
    Sun Z; Wu P; Cui Y; Liu X; Wang K; Gao G; Wang H; Zhang X; Wang X
    J Magn Reson Imaging; 2023 Oct; 58(4):1067-1081. PubMed ID: 36825823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial intelligence as diagnostic aiding tool in cases of Prostate Imaging Reporting and Data System category 3: the results of retrospective multi-center cohort study.
    Wang K; Xing Z; Kong Z; Yu Y; Chen Y; Zhao X; Song B; Wang X; Wu P; Wang X; Xue Y
    Abdom Radiol (NY); 2023 Dec; 48(12):3757-3765. PubMed ID: 37740046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep Learning-Based Interpretable AI for Prostate T2W MRI Quality Evaluation.
    Belue MJ; Law YM; Marko J; Turkbey E; Malayeri A; Yilmaz EC; Lin Y; Johnson L; Merriman KM; Lay NS; Wood BJ; Pinto PA; Choyke PL; Harmon SA; Turkbey B
    Acad Radiol; 2024 Apr; 31(4):1429-1437. PubMed ID: 37858505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database.
    Emmett L; Papa N; Counter W; Calais J; Barbato F; Burger I; Eiber M; Roberts MJ; Agrawal S; Franklin A; Xue A; Rasiah K; John N; Moon D; Frydenberg M; Yaxley J; Stricker P; Wong K; Coughlin G; Gianduzzo T; Kua B; Ho B; Nguyen A; Liu V; Lee J; Hsiao E; Sutherland T; Perry E; Fendler WP; Hope TA
    J Nucl Med; 2024 Jan; 65(1):94-99. PubMed ID: 38050155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram.
    Bjurlin MA; Renson A; Rais-Bahrami S; Truong M; Rosenkrantz AB; Huang R; Taneja SS
    Eur Urol Focus; 2019 Sep; 5(5):815-822. PubMed ID: 29802053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bridging the gap between prostate radiology and pathology through machine learning.
    Bhattacharya I; Lim DS; Aung HL; Liu X; Seetharaman A; Kunder CA; Shao W; Soerensen SJC; Fan RE; Ghanouni P; To'o KJ; Brooks JD; Sonn GA; Rusu M
    Med Phys; 2022 Aug; 49(8):5160-5181. PubMed ID: 35633505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI-RADS
    Yu R; Jiang KW; Bao J; Hou Y; Yi Y; Wu D; Song Y; Hu CH; Yang G; Zhang YD
    Br J Cancer; 2023 Apr; 128(6):1019-1029. PubMed ID: 36599915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
    Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
    J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The added value of AI-based computer-aided diagnosis in classification of cancer at prostate MRI.
    Liu G; Pan S; Zhao R; Zhou H; Chen J; Zhou X; Xu J; Zhou Y; Xue W; Wu G
    Eur Radiol; 2023 Jul; 33(7):5118-5130. PubMed ID: 36725719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.